Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cd4+ Lymphocyte Deficiency”

165 trials

Showing 20 of 165 results

Early research (Phase 1)Study completedNCT00002196
What this trial is testing

CI-1012 in HIV-Infected Patients

Who this might be right for
HIV Infections
Parke-Davis 32
Testing effectiveness (Phase 2)Study completedNCT01734850
What this trial is testing

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Who this might be right for
Human Immunodeficiency Virus
Calimmune, Inc. 13
Not applicableStudy completedNCT00000900
What this trial is testing

The Effects of Illnesses on HIV Levels in the Body

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 26
Early research (Phase 1)Study completedNCT00000645
What this trial is testing

A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 32
Not applicableStudy completedNCT01392430
What this trial is testing

Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected Patients

Who this might be right for
HIV Infection
Chiang Mai University 74
Post-approval studies (Phase 4)Study completedNCT00002376
What this trial is testing

The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 540
Not applicableWithdrawnNCT00001080
What this trial is testing

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT00005779
What this trial is testing

Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Early research (Phase 1)UnknownNCT00006209
What this trial is testing

Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Aaron Diamond AIDS Research Center 24
Not applicableStudy completedNCT00000883
What this trial is testing

Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 636
Large-scale testing (Phase 3)Study completedNCT00000903
What this trial is testing

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 444
Not applicableStudy completedNCT03549546
What this trial is testing

Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery.

Who this might be right for
Lung CancerSurgery
Centre Hospitalier Universitaire de Saint Etienne 31
Not applicableStudy completedNCT00002203
What this trial is testing

Two Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT03666871
What this trial is testing

CCR5-modified CD4+ T Cells for HIV Infection

Who this might be right for
HIV Infections
University of Cincinnati 30
Testing effectiveness (Phase 2)Study completedNCT00000747
What this trial is testing

An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Early research (Phase 1)Study completedNCT00000857
What this trial is testing

Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 65
Not applicableStudy completedNCT00581802
What this trial is testing

HIV Resistance and Treatment Strategies

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 89
Not applicableStudy completedNCT00017771
What this trial is testing

Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs

Who this might be right for
HIV InfectionsPeripheral Nervous System Disease
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableStudy completedNCT00002200
What this trial is testing

1592U89 in HIV-Infected Adults

Who this might be right for
HIV Infections
Glaxo Wellcome
Not applicableUnknownNCT02025322
What this trial is testing

A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDS

Who this might be right for
HIV
Jury Candelario 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation